Member Info for Aberdeenman

There is not even much on twitter, difficult to get a handle on the reason for this, other than news leak/rumours.

Still much more trades than normal coming through.

Decent RNS and this will fly.

Aberdeenman

Resistance around 3.5/3.6, if we clear that then hopefully a climb past 4.

Understandably there will be sellers, based on the low share price for some time. But very good volume, doesn't seem like a PnD, we shall see.

Aberdeenman

Got to be a news leak, NFX does not normally do this kind of volume on no news.

Hopefully that 10 bagger will be upon us very very soon!!!

Aberdeenman

3.5 now being paid

4p next

Averdeenman

something affot, and ties in with the buying we saw previously, looks like there is a leak of positive news!

fingers crossed!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Aberdeenman

MM's getting wind of an RNS???

Aberdeenman

That should, of course, have read NPX002

Aberdeenman

NPX is the most effective treatment for IPF, it does need to be verified, but everything so far has proved that it is the most promising treatment out there. Typically big pharma companies will come along and pick up a treatment a small pharma has researched and patented and run with it.

The damage people are experiencing with Covid has characteristics of IPF, so the amount of potential patients has risen to huge numbers, that is before we even know the full extent.

We don't know when, but the BOD are actively pursuing this avenue, it is only a matter of time.

When it lands expect it to open 10 bagging at least.

Aberdeenman

@£1 profit per test = £130m profit per year @2.5m test per week, however that figure will be a fair amount higher as there will be more profitable sales and tests in the mix.

Add in existing revenue and look at the top line earnings and it still multibags from here on a modest p/e multiple.

Personally, I hope to see a decent brokers note this week with SP higher than current.

If the brokers are worth their salt (I don't think they are) they should also advise a move to the main market.

Aberdeenman

Personally, though, I doubt we will be getting that much for the Gov't test components, but even at £2.5 per test it is still the equivalent of £325m annual revenue from early next year.

Whatever way you crunch the numbers, the SP will still be multiples of the current SP.

Aberdeenman

Pick your price, but revenue is:

@£4 per test = £400k per week now, rising to ~£10m per week early next year @2.5m tests per week

@£5 per test = £500k per week now, rising to ~£12.5m per week early next year @ 2.5m tests per week

With more profitable tests in the mix revenue will be higher.

Even on a modest p/e ratio, the SP will be multiples of current.

Aberdeenman

" I would be fairly keen to get on the phone and get government to confirm order."

The orders will already be in the bag.

The £10m capacity payment tells us that a large order is coming.

The BBI leak tells us the last order was in the bag weeks before it was announced.

The Gov't wants control of announcements to drip news out when things are tough.

I think todays RNS, whilst not earth-shattering is the start of a series of RNS', Broker report will be this week, and several others are likely lined up.

I would not be surprised to see an II holdings TR1 in the next week or two as well.

This hopefully is the start of a serious, news driven, rerate

Aberdeenman

I think today's RNS was also in part to allow the brokers to do a proper calculation. The criticism of them was taken on board, and to allow II's in that report needs to be updated.

Apart from that all is on track, as per CK's presentation.

Remember the uptick in production is not linear, it is more step, with additional machinery and staff allowing expansion, we know they are recruiting.

All good, and I expect more news this week.

Aberdeenman

I think today's RNS was also in part to allow the brokers to do a proper calculation. The criticism of them was taken on board, and to allow II's in that report needs to be updated.

Apart from that all is on track, as per CK's presentation.

Remember the uptick in production is not linear, it is more step, with additional machinery and staff allowing expansion, we know they are recruiting.

All good, and I expect more news this week.

Aberdeenman

Omega is a production partner with Mologic.

Aberdeenman

The Abbott tests are nasal swabs, for POC, whereas Bo Job seems to be talking about tests where you do a swab of saliva from your mouth.

The Mologic LFT is saliva based.

Aberdeenman

"Numbers manufactured will more than make up for that Doctor"

As many will know on here the numbers have been discussed extensively.

At 2.5m tests per week at an average revenue of £3 per test (some will be more some less), plus existing revenue of up to £80-£100m, next year EBITDA should be in the region of £500m, it could be much more.

Working on an extremely conservative p/e ratio of 3 this still multibags from here.

Big orders are coming as per the capacity payment

Everything they make will be sold.

That means this is a no brainer to multi-bag, the only question is when?

It could be anytime, even this week.

Some are talking 500p, it is possible, around 300p seems certain (look at those figures again). Testing is not going away, there will be an abundance of caution over how long antibodies last from vaccinations and looks like none will give lifetime immunity.

ODX will either become a dividend paying, much larger, company, or be snapped up in a spree of M&A activity next year.

As for the discussion re IP, some companies may hold the IP for a test, but these will always be superseded by better tests in the long run, manufacturing will always be needed, and the bar to entry is very very high, just have a look at GMP/CGMP/GLP.

Aberdeenman

No argument from me Safy.

It is obvious very large orders will follow that £10m payment.

Anyone who cannot see what is coming should try premuim bonds.

Aberdeenman

"Very Misleading :You do not know Factually,that Odx will receive orders"

Yawn...

I have seen your type of behaviour thousands of times over the years, it bores me.

£10m capacity payment says very large orders will follow.

Aberdeenman

Sounds to me like we are going to get MHRA approval and very large order in very quick succession.

It also looks like it will happen very soon.

There are only a couple of words required

INEVITABLE and MASSIVE

Aberdeneman